Panelists discuss how guideline-directed medical therapy has evolved to include 4-pillar treatment for heart failure with reduced ejection fraction (angiotensin-converting enzyme ...

Panelists discuss how β-blockers remain foundational therapy for heart failure with reduced ejection fraction (using evidence-based agents like carvedilol, metoprolol succinate, or bisoprolol) with ...

Vericiguat is a candidate for inclusion in guideline-directed medical therapy for heart failure with reduced ejection fraction, based on a meta-analysis showing an all-cause death reduction on top of ...

Please provide your email address to receive an email when new articles are posted on . Digitoxin reduced risk for death or worsening heart failure vs. placebo in patients with heart failure with ...

BOSTON, MA—A digital intervention helps physicians make personalized treatment recommendations for patients with heart failure with reduced ejection fraction (HFrEF) that can enhance uptake of ...

MINNEAPOLIS, MN—Fewer than one-quarter of patients who have heart failure with reduced ejection (HFrEF) and no clinical contraindications to guideline-directed medical therapy (GDMT) are on “quadruple ...

(Cardiome Pharma, Vancouver, BC) reduced serum concentrations of uric acid but failed to improve clinical status over six months in a randomized trial that included a broad population of patients with ...

Tatsuya Yoshida, Mikito Takefuji, and Toyoaki Murohara in the Department of Cardiology, Nagoya University Graduate School of Medicine, identified an enzyme, alpha-kinase 2 (ALPK2) that is specifically ...

A made-in-Calgary 4D heart model is transforming treatment for heart failure patients having a specialized pacemaker inserted ...